Baker Ellis Asset Management LLC Has $3.82 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Baker Ellis Asset Management LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 55,196 shares of the company’s stock after selling 690 shares during the quarter. Baker Ellis Asset Management LLC’s holdings in Henry Schein were worth $3,820,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Cromwell Holdings LLC raised its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Studio Investment Management LLC raised its holdings in Henry Schein by 3.8% in the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after acquiring an additional 200 shares in the last quarter. Huntington National Bank raised its holdings in Henry Schein by 16.8% in the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after acquiring an additional 218 shares in the last quarter. Finally, Bridge Creek Capital Management LLC raised its holdings in Henry Schein by 0.7% in the 4th quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company’s stock valued at $2,682,000 after acquiring an additional 260 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on HSIC. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Seven analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $79.40.

Henry Schein Trading Up 0.8 %

Shares of HSIC stock opened at $74.78 on Thursday. The stock has a market cap of $9.32 billion, a price-to-earnings ratio of 30.77, a PEG ratio of 2.03 and a beta of 0.89. The stock has a 50-day moving average of $72.70 and a 200-day moving average of $70.86. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.32 earnings per share. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.